NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Hb:

With all due respect, I have heard it all before no less than from a Senior VP and former Skadden Arps partner in Washington, DC. DI is continuing the party line. Things have to be aligned just right, the timing is not propitious, the tea leaves have to fall in place and the moon positioned perfectly for the full eclipse, yada,yada,yada.

It was expected by many that top line would be announced by end of 2018 or even in early 2019. Here we are almost half a year later and most probably no announcement or even meaningful news at ASCO 2019. This follows a pattern of dragging on and on for whatever excuse. ASCO 2019 is the watershed event. Essentially if nothing new is revealed, the share price collapses. Perhaps the problem is that management fears the results won't be unequivocal and undeniable. They will need to be defended and explained. NWBO will once again be placed on the defensive and will retreat, as usual, into its lair of silence. Thus the delay. NWBO management is now thinking of how they can explain away less than stellar results. It is beginning to look that way.

Flipper is correct. The time to unblind is well nigh. It is disadvantageous to continue collecting events as patients are older and will die from other causes.

I bet that the SAPs have not even been completed and much more submitted to the RAs. Nothing will be said in the updates except stay tuned. That's a pattern you can depend upon and take to the bank. JMHO.